Literature DB >> 16585126

Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE.

A Nyboe Andersen, L Gianaroli, R Felberbaum, J de Mouzon, K G Nygren.   

Abstract

European results of assisted reproductive techniques (ART) from treatments initiated during 2002 are presented in this sixth report. Data was mainly collected from already existing national registers. From 25 countries, 631 clinics reported 324,238 treatment cycles with: IVF 122,634, ICSI 135,048, frozen embryo replacement (FER) 57 162, egg donation (ED) 7677, preimplantation genetic diagnosis/screening (PGD/PGS) 1563 and in vitro maturation (IVM) 154. Overall this represents a 12% increase since year 2001. For the second time, results on European data on intrauterine inseminations were reported from 17 countries. A total of 93,284 cycles [IUI-husband/partner (H), 78 505 and IUI-donor (D), 14,779] were included. In 13 countries where all clinics reported to the register, a total of 177,429 cycles were performed in a population of 193.7 million, corresponding to 916 cycles per million inhabitants. For IVF the clinical pregnancy rate per aspiration and per transfer was 26.0 and 29.5%, respectively. For ICSI the corresponding rates were 27.2 and 29.4%. These figures are marginally better than in 2001. After IUI-H the clinical pregnancy rate was 11.6% in women below 40 and 7.8% in women>or=40 years of age. After IVF and ICSI the distribution of transfer of 1, 2, 3 and 4 or more embryos was 13.7, 54.8, 26.9 and 4.7%, respectively. Compared with year 2001, less embryos were transferred, but huge differences existed between countries. The distribution of singleton, twin and triplet deliveries for IVF and ICSI combined was 75.5, 23.2 and 1.3%, respectively. This gives a total multiple delivery rate of 24.5%, compared with 25.5% in year 2001. The range of triplet deliveries after IVF and ICSI varied from 0.0 to 5.2% between countries. After IUI-H in women below 40 years of age, 10.2% were twin and 1.3% triplet gestations.

Entities:  

Mesh:

Year:  2006        PMID: 16585126     DOI: 10.1093/humrep/del075

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  30 in total

1.  The future of neo-eugenics. Now that many people approve the elimination of certain genetically defective fetuses, is society closer to screening all fetuses for all known mutations?

Authors:  Armand Marie Leroi
Journal:  EMBO Rep       Date:  2006-12       Impact factor: 8.807

2.  Intrauterine insemination with husband semen: an evaluation of pregnancy rate and factors affecting outcome.

Authors:  Shahrzad Zadehmodarres; Belgheis Oladi; Shahrbanoo Saeedi; Fatemeh Jahed; Haleh Ashraf
Journal:  J Assist Reprod Genet       Date:  2008-11-22       Impact factor: 3.412

Review 3.  Public financing of IVF: a review of policy rationales.

Authors:  Philipa Mladovsky; Corinna Sorenson
Journal:  Health Care Anal       Date:  2009-04-03

4.  DNA methylation and gene expression differences in children conceived in vitro or in vivo.

Authors:  Sunita Katari; Nahid Turan; Marina Bibikova; Oluwatoyin Erinle; Raffi Chalian; Michael Foster; John P Gaughan; Christos Coutifaris; Carmen Sapienza
Journal:  Hum Mol Genet       Date:  2009-07-15       Impact factor: 6.150

5.  Comparison of chromosomal abnormality rates in ICSI for non-male factor and spontaneous conception.

Authors:  Banu Bingol; Faruk Abike; Ali Gedikbasi; Omer Lutfi Tapisiz; Ziya Gunenc
Journal:  J Assist Reprod Genet       Date:  2011-10-25       Impact factor: 3.412

6.  Comments on the release of the 5th edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen.

Authors:  W C L Ford
Journal:  Asian J Androl       Date:  2010-01       Impact factor: 3.285

7.  Estimating the relative contributions of maternal genetic, paternal genetic and intrauterine factors to offspring birth weight and head circumference.

Authors:  Frances Rice; Anita Thapar
Journal:  Early Hum Dev       Date:  2010-06-20       Impact factor: 2.079

8.  In vitro fertilization and multiple pregnancies: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-10-01

9.  Successful pregnancy after rituximab in a women with recurrent in vitro fertilisation failures and anti-phospholipid antibody positive.

Authors:  C T Ng; M O'Neil; D Walsh; T Walsh; D J Veale
Journal:  Ir J Med Sci       Date:  2009-12       Impact factor: 1.568

10.  Exposure to a complex cocktail of environmental endocrine-disrupting compounds disturbs the kisspeptin/GPR54 system in ovine hypothalamus and pituitary gland.

Authors:  Michelle Bellingham; Paul A Fowler; Maria R Amezaga; Stewart M Rhind; Corinne Cotinot; Beatrice Mandon-Pepin; Richard M Sharpe; Neil P Evans
Journal:  Environ Health Perspect       Date:  2009-06-05       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.